ScholarIQanswers from OpenAlex

Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses

PaperCitations, authors & open-access status

Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses have?

ScholarIQcitation count

Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses has 150 citations in the OpenAlex counts ScholarIQ stores.

When was Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses published?

ScholarIQyear

Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses has 2022 year in the ScholarIQ index.

What is the open-access status of Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses?

ScholarIQoa status

Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses has gold oa status in the ScholarIQ index.

What is the DOI of Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses?

ScholarIQdoi

The DOI for Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses is on the source record.

What is the PMID of Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses?

ScholarIQpmid

The PMID for Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses is on the source record.

What is the OpenAlex record for Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses?

ScholarIQopenalex

The OpenAlex for Universal immunotherapeutic strategy for hepatocellular carcinoma with exosome vaccines that engage adaptive and innate immune responses is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial